Global Predictive Biomarkers Market Size is valued at USD 24.4 Bn in 2024 and is predicted to reach USD 126.3 Bn by the year 2034 at a 18.0% CAGR during the forecast period for 2025-2034
Predictive biomarkers are biological traits or molecular signals that can predict how a person might respond to a specific treatment or intervention. These biomarkers are used in a variety of sectors, such as medicine, pharmacology, and personalized healthcare, to forecast a patient's reaction to a given medication or to identify individuals who are more likely to benefit from a specific treatment.
The growing emphasis on personalized treatment and targeted medicines has been a major driving force in the predictive biomarkers market. The need for biomarker-based diagnostics and therapeutics has increased as healthcare practitioners strive to improve treatment outcomes while minimizing side effects. However, the pandemic hampered clinical trials in a variety of therapeutic fields, including those using predictive biomarkers. Many trials were halted, postponed, or adjusted to address safety concerns and alter healthcare priorities.
The Predictive Biomarkers Market is segmented on the basis of indication and end-use. As per the segment indication, the market is segmented as cancer, neurological disorder, cardiovascular disorder, immunological disorder, and others. The end-user segment includes diagnostic centers, Contract Research Organizations (CROs), academic research institutes, pharma & biotech companies, and others.
The diagnostic centers' category is expected to hold a major share of the global Predictive Biomarkers Market in 2022. The increasing use of biomarkers in the detection of diseases such as cancer and others is a primary element driving the segment's revenue growth. The widespread availability of Deoxyribonucleic Acid (DNA) biomarker tests is helping to drive revenue growth in this market. Other important factors driving revenue growth in the market during the projected period include rapid technical breakthroughs and the use of technologies such as microarrays, next-generation sequencing techniques & mass spectrometry for nucleic acids.
The cancer segment is projected to grow at a rapid rate in the global Predictive Biomarkers Market. The rising incidence of cancer around the world is primarily responsible for the segment's growth. Cancer is the leading cause of death in every country and a substantial impediment to extending life expectancy. According to the American Cancer Society, there will be about 236,740 lung cancer patients in the United States by 2022. Additionally, increased demand for personalized medication is contributing to the segment's revenue growth.
The North American Predictive Biomarkers Market is expected to register the maximum market share in terms of revenue in the near future. Significant investments in healthcare infrastructure, as well as the quick use of biomarkers, are key drivers of market revenue development in this area. Rising cancer and other disease incidences are driving market revenue growth. Market enterprises operating in this region's various countries are establishing awareness programs connected to disease diagnosis and early screening, as well as the search for potential treatment solutions.
These activities have a substantial impact on market revenue growth. Moreover, Europe is expected to grow significantly in the coming years. Rapid technical improvements, as well as the presence of firms such as F. Hoffman-La Roche Ltd., Siemens Healthcare GmbH, and others, are driving market revenue growth in this region. Significant investments in R&D activities are helping the market's revenue growth in this region.
Report Attribute |
Specifications |
Market Size Value In 2024 |
USD 24.4 Bn |
Revenue Forecast In 2034 |
126.3 Bn |
Growth Rate CAGR |
CAGR of 14.27 % from 2023 to 2031 |
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
Historic Year |
2019 to 2022 |
Forecast Year |
2023-2031 |
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
Segments Covered |
By Indication, End-User |
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
Competitive Landscape |
Thermo Fisher Scientific Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Illumina Inc., Merck KGaA, Bio-Techne Corporation, Siemens Healthineers AG, PerkinElmer Inc, Pacific Biosciences of California, Inc., Genomic Health, Inc., Danaher Corporation, Becton, Dickinson and Company, and Myriad Genetics, Inc |
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Predictive Biomarkers Market Snapshot
Chapter 4. Global Predictive Biomarkers Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Indication Estimates & Trend Analysis
5.1. By Indication & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Indication:
5.2.1. Cancer
5.2.2. Neurological Disorder
5.2.3. Cardiovascular Disorder
5.2.4. Immunological Disorder
5.2.5. Others
Chapter 6. Market Segmentation 2: By End Use Estimates & Trend Analysis
6.1. By Indication & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End Use:
6.2.1. Diagnostic Centers
6.2.2. Contract Research Organizations (CROs)
6.2.3. Academic Research Institutes
6.2.4. Pharma and Biotech companies
6.2.5. Others
Chapter 7. Predictive Biomarkers Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Predictive Biomarkers Market revenue (US$ Million) estimates and forecasts By Indication, 2021-2034
7.1.2. North America Predictive Biomarkers Market revenue (US$ Million) estimates and forecasts By End Use, 2021-2034
7.1.3. North America Predictive Biomarkers Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Predictive Biomarkers Market revenue (US$ Million) By Indication, 2021-2034
7.2.2. Europe Predictive Biomarkers Market revenue (US$ Million) By End Use, 2021-2034
7.2.3. Europe Predictive Biomarkers Market revenue (US$ Million) by country, 2021-2034
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.4. Spain
7.2.4.1. UK
7.2.4.2. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Predictive Biomarkers Market revenue (US$ Million) By Indication, 2021-2034
7.3.2. Asia Pacific Predictive Biomarkers Market revenue (US$ Million) By End Use, 2021-2034
7.3.3. Asia Pacific Predictive Biomarkers Market revenue (US$ Million) by country, 2021-2034
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Predictive Biomarkers Market revenue (US$ Million) By Indication, 2021-2034
7.4.2. Latin America Predictive Biomarkers Market revenue (US$ Million) By End Use, 2021-2034
7.4.3. Latin America Predictive Biomarkers Market revenue (US$ Million) by country, (US$ Million) 2021-2034
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. Middle East & Africa
7.5.1. Middle East & Africa Predictive Biomarkers Market revenue (US$ Million) By Indication, (US$ Million)
7.5.2. Middle East & Africa Predictive Biomarkers Market revenue (US$ Million) By End Use, (US$ Million)
7.5.3. Middle East & Africa Predictive Biomarkers Market revenue (US$ Million) by country, (US$ Million) 2021-2034
7.5.3.1. South Africa
7.5.3.2. GCC Countries
7.5.3.3. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Siemens Healthcare GmbH
8.2.2. F. Hoffman-La Roche Ltd
8.2.3. General Electric Company
8.2.4. Abbott
8.2.5. QIAGEN
8.2.6. Johnson & Johnson Services, Inc.
8.2.7. PerkinElmer Inc.
8.2.8. Thermo Fisher Scientific
8.2.9. Almac Group
8.2.10. Merck KGaA
Predictive Biomarkers Market By Indication-
Predictive Biomarkers Market By End-Use-
Predictive Biomarkers Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.